766 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
Dividend Growth ETFs for Long Term Investors http://www.zacks.com/stock/news/517301/dividend-growth-etfs-for-long-term-investors?cid=CS-ZC-FT-etf_news_and_commentary-517301 Sep 13, 2019 - Dividend growth ETFs hold companies with solid balance sheets and rising earnings.
Coalition urges FTC block to ABBV-AGN deal https://seekingalpha.com/news/3499276-coalition-urges-ftc-block-abbv-agn-deal?source=feed_news_all Sep 13, 2019 - Consumer groups and unions want the FTC to block AbbVie's (ABBV +0.4%) $63B acquisition of Allergan (AGN), according to a STAT report.The coalition says the increasingly concentrated nature of the hea
Vertex Gains Reimbursement for Orkambi & Symkevi in Scotland http://www.zacks.com/stock/news/516985/vertex-gains-reimbursement-for-orkambi-symkevi-in-scotland?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-516985 Sep 13, 2019 - Vertex (VRTX) secures reimbursement nods in Scotland for its cystic fibrosis drugs Orkambi and Symkevi.
Anxious About AbbVie? Here Are 4 Things You Should Know https://www.fool.com/investing/2019/09/12/anxious-about-abbvie-here-are-4-things-you-should.aspx?source=iedfolrf0000001 Sep 12, 2019 - The situation for AbbVie probably isn't nearly as bad as you think it is.
4 Big Drugmakers Boasting Impressive Oncology Pipelines http://www.zacks.com/stock/news/513001/4-big-drugmakers-boasting-impressive-oncology-pipelines?cid=CS-ZC-FT-analyst_blog|industry_focus-513001 Sep 11, 2019 - We discuss four pharma giants, which possess the industry's strongest oncology pipeline portfolios.
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio http://www.zacks.com/stock/news/512942/why-abbvie-abbv-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-512942 Sep 11, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie Inc. (ABBV) CEO Rick Gonzalez Presents at Morgan Stanley Healthcare Conference (Transcript) https://seekingalpha.com/article/4290816-abbvie-inc-abbv-ceo-rick-gonzalez-presents-morgan-stanley-healthcare-conference-transcript?source=feed_sector_transcripts Sep 10, 2019 - AbbVie Inc. (NYSE:ABBV) Morgan Stanley Healthcare Conference September 10, 2019 11:00 AM ET Company Participants Rick Gonzalez - Chairman & Chief Executive Officer Rob Michael - Executive Vice Pre
The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels http://www.zacks.com/stock/news/509524/the-zacks-analyst-blog-highlights-microsoft-home-depot-abbvie-disney-and-host-hotels?cid=CS-ZC-FT-press_releases-509524 Sep 09, 2019 - The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels
Top Stock Reports for Microsoft, Home Depot & AbbVie http://www.zacks.com/research-daily/504832/top-stock-reports-for-microsoft-home-depot-abbvie?cid=CS-ZC-FT-research_daily-504832 Sep 06, 2019 - Top Stock Reports for Microsoft, Home Depot & AbbVie
J&J's Stelara Gets Approval in EU for Ulcerative Colitis http://www.zacks.com/stock/news/503348/jjs-stelara-gets-approval-in-eu-for-ulcerative-colitis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503348 Sep 05, 2019 - Johnson & Johnson (JNJ) receives European Commission's (EC) approval for the label expansion of Stelara for the treatment of adults with moderately-to-severely active ulcerative colitis (UC).

Pages: 1234567891011...77

<<<Page 6>